Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory Activity.

导出 LinkOut

翻译打印收藏纠错

第一作者： Burcu,Uner

第一单位： Institute of Graduate Studies in Health Sciences, Istanbul University, Istanbul, Turkey. burcu.uner@uhsp.edu.

作者： Burcu,Uner ^[1] ; Samet,Ozdemir ^[2] ; Cetin,Tas ^[3] ; Melike,Uner ^[4] ; Yildiz,Ozsoy ^[5]

作者单位： Institute of Graduate Studies in Health Sciences, Istanbul University, Istanbul, Turkey. burcu.uner@uhsp.edu. ^[1] Faculty of Pharmacy, Yeditepe University, Atasehir, 34755, Istanbul, Turkey. burcu.uner@uhsp.edu. ^[2] University of Health Science and Pharmacy in St. Louis, 1 Pharmacy Place, St. Louis, Missouri, 63110-1088, USA. burcu.uner@uhsp.edu. ^[3] Faculty of Pharmacy, Istanbul Health and Technology University, Zeytinburnu, 34010, Istanbul, Turkey. ^[4] Faculty of Pharmacy, Yeditepe University, Atasehir, 34755, Istanbul, Turkey. ^[5] Faculty of Pharmacy, Istanbul University, Beyazıt, 34116, Istanbul, Turkey. ^[6]

关键词 design of experiments loteprednol etabonate nanoemulsion nanostructured lipid carriers ophthalmic delivery quality by design solid lipid nanoparticles topical corticosteroids

主题词人类(Humans);药物载体(Drug Carriers);脂类(Lipids);纳米粒子(Nanoparticles);消炎药(Anti-Inflammatory Agents);角膜(Cornea);粒子大小(Particle Size)

DOI 10.1208/s12249-023-02551-6

PMID 36977841

发布时间 2023-03-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交